None of the over 2,000 young women and girls injected twice a year with a new drug, lenacapavir, contracted HIV in one of the most important advances...

WHO estimates that there are 39 million HIV patients living in the world with a death rate of around 630,000 per year. A figure that seems high but 20...

Results of a phase 3 PURPOSE 1 HIV prevention study done among adolescent girls and young women in South Africa and Uganda show that there were no...

A promising new HIV prevention drug called lenacapavir has shown 100 percent efficacy in a clinical trial among adolescent girls and young women in...

Injectable HIV Prevention Drug Shows Promising Results By Thuku Kariuki and Daniel Furnad An injectable medication to prevent the transmission of HIV,...

Gilead's (GILD) twice-yearly, subcutaneous lenacapavir has demonstrated its potential as a new tool to help prevent HIV infections with zero...

The new drug developed by an American pharmaceutical company yielded 100% results in HIV prevention, according to the developer Read Full Article at...

The Reels algorithm may be stronger than the platform can handle. Young Instagram users are more easily recommended sexually explicit and harmful...

Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), BP p.l.c. (BP) and Gilead Sciences, Inc....